These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 24853636)
1. Implications of Look AHEAD for clinical trials and clinical practice. Wing RR; Diabetes Obes Metab; 2014 Dec; 16(12):1183-91. PubMed ID: 24853636 [TBL] [Abstract][Full Text] [Related]
2. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. ; Wing RR Arch Intern Med; 2010 Sep; 170(17):1566-75. PubMed ID: 20876408 [TBL] [Abstract][Full Text] [Related]
3. Association of Weight Loss Maintenance and Weight Regain on 4-Year Changes in CVD Risk Factors: the Action for Health in Diabetes (Look AHEAD) Clinical Trial. Wing RR; Espeland MA; Clark JM; Hazuda HP; Knowler WC; Pownall HJ; Unick J; Wadden T; Wagenknecht L; Diabetes Care; 2016 Aug; 39(8):1345-55. PubMed ID: 27271190 [TBL] [Abstract][Full Text] [Related]
4. Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study. ; Bray G; Gregg E; Haffner S; Pi-Sunyer XF; WagenKnecht LE; Walkup M; Wing R Diab Vasc Dis Res; 2006 Dec; 3(3):202-15. PubMed ID: 17160917 [TBL] [Abstract][Full Text] [Related]
5. The results of Look AHEAD do not row against the implementation of lifestyle changes in patients with type 2 diabetes. Annuzzi G; Rivellese AA; Bozzetto L; Riccardi G Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):4-9. PubMed ID: 24388434 [TBL] [Abstract][Full Text] [Related]
6. Effect of improved fitness beyond weight loss on cardiovascular risk factors in individuals with type 2 diabetes in the Look AHEAD study. Gibbs BB; Brancati FL; Chen H; Coday M; Jakicic JM; Lewis CE; Stewart KJ; Clark JM; Eur J Prev Cardiol; 2014 May; 21(5):608-17. PubMed ID: 23012688 [TBL] [Abstract][Full Text] [Related]
7. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Ryan DH; Espeland MA; Foster GD; Haffner SM; Hubbard VS; Johnson KC; Kahn SE; Knowler WC; Yanovski SZ; Control Clin Trials; 2003 Oct; 24(5):610-28. PubMed ID: 14500058 [TBL] [Abstract][Full Text] [Related]
8. Effects of visceral adipose tissue reduction on CVD risk factors independent of weight loss: The Look AHEAD study. Sanguankeo A; Lazo M; Upala S; Brancati FL; Bonekamp S; Pownall HJ; Balasubramanyam A; Clark JM; Endocr Res; 2017 May; 42(2):86-95. PubMed ID: 27351077 [TBL] [Abstract][Full Text] [Related]
9. Fiber intake and plasminogen activator inhibitor-1 in type 2 diabetes: Look AHEAD (Action for Health in Diabetes) trial findings at baseline and year 1. Belalcazar LM; Anderson AM; Lang W; Schwenke DC; Haffner SM; Yatsuya H; Rushing J; Vitolins MZ; Reeves R; Pi-Sunyer FX; Tracy RP; Ballantyne CM; J Acad Nutr Diet; 2014 Nov; 114(11):1800-10.e2. PubMed ID: 25131348 [TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of Treatment Effects From an Intensive Lifestyle Weight Loss Intervention on Cardiovascular Events in Patients With Type 2 Diabetes: Data From the Look AHEAD Trial. de Vries TI; Dorresteijn JAN; van der Graaf Y; Visseren FLJ; Westerink J Diabetes Care; 2019 Oct; 42(10):1988-1994. PubMed ID: 31416897 [TBL] [Abstract][Full Text] [Related]
11. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. Franz MJ; Boucher JL; Rutten-Ramos S; VanWormer JJ J Acad Nutr Diet; 2015 Sep; 115(9):1447-63. PubMed ID: 25935570 [TBL] [Abstract][Full Text] [Related]
12. Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study. Belalcazar LM; Ballantyne CM; Lang W; Haffner SM; Rushing J; Schwenke DC; Pi-Sunyer FX; Tracy RP; Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1689-95. PubMed ID: 21512162 [TBL] [Abstract][Full Text] [Related]
13. Effect of lifestyle intervention on cardiometabolic risk factors: results of the POWER-UP trial. Vetter ML; Wadden TA; Chittams J; Diewald LK; Panigrahi E; Volger S; Sarwer DB; Moore RH; Int J Obes (Lond); 2013 Aug; 37 Suppl 1(0 1):S19-24. PubMed ID: 23921777 [TBL] [Abstract][Full Text] [Related]
14. Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study. Jakicic JM; Jaramillo SA; Balasubramanyam A; Bancroft B; Curtis JM; Mathews A; Pereira M; Regensteiner JG; Ribisl PM; Int J Obes (Lond); 2009 Mar; 33(3):305-16. PubMed ID: 19153582 [TBL] [Abstract][Full Text] [Related]
15. The long-term effectiveness of a lifestyle intervention in severely obese individuals. Unick JL; Beavers D; Bond DS; Clark JM; Jakicic JM; Kitabchi AE; Knowler WC; Wadden TA; Wagenknecht LE; Wing RR; Am J Med; 2013 Mar; 126(3):236-42, 242.e1-2. PubMed ID: 23410564 [TBL] [Abstract][Full Text] [Related]
16. Patterns of weight change associated with long-term weight change and cardiovascular disease risk factors in the Look AHEAD Study. Neiberg RH; Wing RR; Bray GA; Reboussin DM; Rickman AD; Johnson KC; Kitabchi AE; Faulconbridge LF; Kitzman DW; Espeland MA; Obesity (Silver Spring); 2012 Oct; 20(10):2048-56. PubMed ID: 22327053 [TBL] [Abstract][Full Text] [Related]
17. Lifestyle intervention and/or statins for the reduction of C-reactive protein in type 2 diabetes: from the look AHEAD study. Belalcazar LM; Haffner SM; Lang W; Hoogeveen RC; Rushing J; Schwenke DC; Tracy RP; Pi-Sunyer FX; Kriska AM; Ballantyne CM; Obesity (Silver Spring); 2013 May; 21(5):944-50. PubMed ID: 23512860 [TBL] [Abstract][Full Text] [Related]
18. Impact of Intensive Lifestyle Intervention on Disability-Free Life Expectancy: The Look AHEAD Study. Gregg EW; Lin J; Bardenheier B; Chen H; Rejeski WJ; Zhuo X; Hergenroeder AL; Kritchevsky SB; Peters AL; Wagenknecht LE; Ip EH; Espeland MA; Diabetes Care; 2018 May; 41(5):1040-1048. PubMed ID: 29545462 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. ; Wing RR; Bolin P; Brancati FL; Bray GA; Clark JM; Coday M; Crow RS; Curtis JM; Egan CM; Espeland MA; Evans M; Foreyt JP; Ghazarian S; Gregg EW; Harrison B; Hazuda HP; Hill JO; Horton ES; Hubbard VS; Jakicic JM; Jeffery RW; Johnson KC; Kahn SE; Kitabchi AE; Knowler WC; Lewis CE; Maschak-Carey BJ; Montez MG; Murillo A; Nathan DM; Patricio J; Peters A; Pi-Sunyer X; Pownall H; Reboussin D; Regensteiner JG; Rickman AD; Ryan DH; Safford M; Wadden TA; Wagenknecht LE; West DS; Williamson DF; Yanovski SZ N Engl J Med; 2013 Jul; 369(2):145-54. PubMed ID: 23796131 [TBL] [Abstract][Full Text] [Related]
20. Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus?: The Action for Health in Diabetes (Look AHEAD) study. Huggins GS; Papandonatos GD; Erar B; Belalcazar LM; Brautbar A; Ballantyne C; Kitabchi AE; Wagenknecht LE; Knowler WC; Pownall HJ; Wing RR; Peter I; McCaffery JM; Circ Cardiovasc Genet; 2013 Aug; 6(4):391-9. PubMed ID: 23861364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]